The MIP, if approved, may potentially enable domestic capacity to survive the price onslaught of Chinese suppliers and will also make Aurobindo Pharma's investment under India’s Production-Linked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback